Cochlear Implants
by Cochlear Guest Author

Cochlear™ remains #1 in implant reliability according to latest report

May 28, 2019
Share

By Wade Colburn, Product Manager, Cochlear Implants at Cochlear Americas

For almost 40 years, Cochlear has partnered with professionals across the globe to guide individuals with hearing loss into the world of sound.

Today, the Cochlear™ Nucleus® system is the most implanted cochlear implant device with more than 379,000 implants globally1, keeping people connected to the world, and each other, through sound.

During the initial stages of the patient journey, choosing an implant system is an important decision and product reliability is a primary consideration. While candidates seek a device that delivers high sound quality performance and cutting-edge technology for connectivity, they also want the peace of mind that their implant will stand the test of time.

To demonstrate Cochlear’s ongoing commitment to a lifetime of sound, device reliability reporting is completed and published annually according to the European and Global Consensus Statement on Cochlear Implant Failures and Explantations2. This widely recognized resource established the seven principles of best practice reporting and details how device failures and reliability should be reported to maintain uniformity and consistency across manufacturers.

The most recent Cochlear implant reliability report (Volume 17) is now available and maintains consistently high ratings across the product portfolio.  The Cochlear Profile Series demonstrates a cumulative survival percentage (CSP) of 99.82% within 5 years of implantation, while the Cochlear Freedom Series remains at 99.00% within 14 years1.  These market-leading results validate that Cochlear continues to be not only the most implanted manufacturer, but also the most reliable. Applying the globally sanctioned quality reporting standards to devices from other cochlear implant manufacturers demonstrates this fact:

  • Cochlear Profile: 1 in 556 devices fail within 5 years1
  • Advanced Bionics® HiRes™ 90K Advantage: 1 in 141 devices fail within 5 years3
  • MED-EL® SYNCHRONY: 1 in 55 devices fail within 3 years4

Constantly striving to improve reliability is a cornerstone of Cochlear’s implant design process and is among the most important features patients consider when selecting a cochlear implant. Our consistent best-in-class reliability rating illustrates our commitment to supporting a lifetime of hearing for our recipients, so they may Hear now. And always

View the latest report and learn more about Cochlear implant reliability.

About our guest author:

Wade ColburnWade Colburn is the Product Manager for the Cochlear™ Implant product portfolio within Cochlear Americas.  Wade’s responsibilities include product positioning and messaging, life-cycle management, new product launches and surgical support and training. Wade has recently joined Cochlear and comes from an engineering background within the medical device field, including previous otology experience.

 

References:
1. Cochlear Nucleus Implant Reliability Report. Volume 17 | December 2018. D1593476. Cochlear Ltd; 2018
2.  European Consensus Statement on Cochlear Implant Failures and Explantations. Otol Neurotol. 26: 1097-1099, 2005.
3. 2018 Global Reliability Report. 027-N025-02 Rev B. Advanced Bionics AG and Affiliates.; 2018.
4. Hearing Implant Reliability Reporting | MEDEL [Internet]. MedEl.com. 2018 [cited 24 Oct 2018]. Available from: https://www.medel.com/us/reliabilityreporting.
© Cochlear Limited 2019. All rights reserved. Hear now. And always and other trademarks and registered trademarks are the property of Cochlear Limited or Cochlear Bone Anchored Solutions AB. The names of actual companies and products mentioned herein may be the trademarks of their respective owners.

 

Author

Cochlear Guest Author

In an effort to keep our content fresh and reflective of a diverse industry, Cochlear Americas features a mix of employees and professional partners to contribute to Cochlear ProNews as Guest Authors.

View all posts

Related Posts

The discreet Kanso® Sound Processor is the only off-the-ear cochlear implant sound processor with dual microphone technology

January 16, 2018

wearyourway

The Cochlear™ Kanso® Sound Processor is the only off-the-ear (OTE) cochlear implant sound processor with dual microphones and SmartSound® iQ with SCAN*.

Kanso dual microphones can enhance a recipient’s ability to hear in noisy environments by up to 30%.1,2 Combined with SmartSound iQ with SCAN, Kanso dual microphones allow the sound processor to automatically adjust to different listening environments, providing a seamless hearing experience.2,3

The Kanso Sound Processor is designed to be light, discreet and comfortable. As an off-the-ear option, it is the smallest in the industry.4,5

See why patients love the discreet and comfortable Kanso sound processor.

See what your patients are learning about the Kanso sound processor.

Cochlear logo

*SNR-NR and WNR are approved for use with any recipient ages 6 years and older, who is able to 1) complete objective speech perception testing in quiet and in noise in order to determine and document performance 2) report a preference for different program settings. SCAN is FDA approved for use with any recipient age 6 years old and older, to be used at the discretion of the recipient/parent/caregiver
  1. Amlani AM. Efficacy of directional microphone hearing aids: a meta-analytic perspective. J Am Acad Audiol 2001;12(4):202-14.
  2. Stefan J. Mauger, Marian Jones, Esti Nel & Janine Del Dot (2017) Clinical outcomes with the Kanso™ off-the-ear cochlear implant sound processor, International Journal of Audiology, 56:4, 267-276, DOI: 10.1080/14992027.2016.1265156
  3. Cochlear Limited, A clinical comparison of the Cochlear™Nucleus®5 noise management options, Cochlear White Paper; 2010, N34545F JUN10 ISS1.
  4. Cochlear Limited. CP950 Kanso Sound Processor User Guide. Data on file, July 2016.
  5. MED-EL Medical Electronics. RONDO User Manual. Last accessed July 2016. Available at: https://www.medel.com/int/rondo.
young girl playing with bubbles

Cochlear Clinical Quick Tips: Confirming the Auditory Response Intra-Operatively

May 4, 2017

Providing peace of mind and additional confirmation during cochlear implant surgery with the Nucleus CR220 Intraoperative Remote Assistant.

 

For a new Cochlear™ recipient and their family, knowing that the cochlear implant is functioning as their surgeon and audiologist expected, and that the auditory nerve is responding to stimulation, can be reassuring. For the audiologist and surgeon, knowing that electrode impedances are appropriate, and that AutoNRT® thresholds were measured provides confidence that the surgical procedure was successful. In the past, a laptop with Custom Sound®, a programming pod, and associated cables were required to obtain this information – and it was typically in the purview of the audiologist to take time out of his or her schedule to complete the testing. To address these challenges, Cochlear partnered with surgeons and clinicians to expand the capabilities of the industry-first bidirectional remote assistant to provide this valuable information more quickly, and by anyone in the operating room. Using the CR220 Intraoperative Remote Assistant means obtaining confidence that all electrodes are functioning, and that the auditory nerve is responding to stimulation, has never been easier, faster or more efficient!

 Below is some helpful information to know when working with the CR220 Intraoperative Remote Assistant:

  1. Before using the CR220 in the operating room for the first time, you can learn how it works via the onboard Practice Mode. Simply press and hold the OK button, press the down arrow to highlight Practice Mode, and press OK. Be sure to explore the screens accessed by pressing the right side arrow before, during and after testing. You may wish to turn off the Beeps on Remote under Settings before starting your practice session.
  2. The operating range between the CR220 Remote Assistant and the CP810 processor is up to 6 feet.
  3. For simplicity, the CR220 uses the same intraoperative AutoNRT® parameters as Custom Sound®
    1. Stimulation rate of 250Hz
    2. Measurement starts at 170 current level (CL), after a conditioning stimulus of 230 CL for each electrode.
    3. All 22 intracochlear electrodes are measured starting with Electrode 22, followed by Electrode 1, 11, 6, 16 and so on.

Note: AutoNRT has a high success rate of obtaining threshold NRT (T-NRT) on 93 percent of electrodes, which is better than any other cochlear implant objective measure.1

  1. The CR220 Intraoperative Remote Assistant has clear, simple messages to inform you of any actions you may need to take during testing. Below are just two examples.

          a. If the connection to the internal device is lost, the following will be shown on the CR220’s display screen:

  • A prompt to ‘Reconnect coil to Implant.’ You will have five minutes to reconnect, otherwise the test session will conclude.  If this occurs, you can initiate a new session to collect your data.

          b. After pressing the OK button to pause AutoNRT while it is running you will see:

  • Resume AutoNRT: the device will simply continue testing from where it was paused.
  • View Results: use the arrow keys to see the acquired NRT profile or individual NRT traces.
  • Either Cancel AutoNRT or Finish AutoNRT If you cancel AutoNRT before three electrode measurements are completed, the Auto NRT Cancelled screen will display. Press the OK button to return to the NRT: Electrodes screen to re-start. If you stop AutoNRT after three or more electrode measurements are completed, you will have the option to Finish AutoNRT.

We hope that using the CR220 Intraoperative Remote Assistant enhances your confidence in surgery, reduces your clinical load and complexity, and enhances your clinic efficiency.

If you would like to learn more about the CR220, please visit our one-hour (CEU available) Audiology Online course using the following link:

*van Dijk, B., Botros, A., Battmer, R., Begall, K., Dillier, N., Hey, M., Lai, W., Lenarz, T., Laszig, R., Morsnowski, A., Muller-Deile, J., Psarros, C., Shallop, J., Weber, B., Wesarg, T., Zarowski, A. & Offeciers, E. (2007) . Clinical results of AutoNRT: A completely automatic ECAP recording system for cochlear implants. Ear and Hearing. 28:4, 558-570

©Cochlear Limited 2017. All rights reserved. Hear now. And always and other trademarks and registered trademarks are the property of Cochlear Limited or Cochlear Bone Anchored Solutions AB. The names of actual companies and products mentioned herein may be the trademarks of their respective owners.

Cochlear logo - white

©Cochlear Limited 2024. All rights reserved. ACE, Advance Off-Stylet, AOS, Ardium, AutoNRT, Autosensitivity, Baha, Baha SoftWear, BCDrive, Beam, Bring Back the Beat, Button, Carina, Cochlear, 科利耳, コクレア, 코클리어, Cochlear SoftWear, Contour, コントゥア, Contour Advance, Custom Sound, DermaLock, Freedom, Hear now. And always, Hugfit, Human Design, Hybrid, Invisible Hearing, Kanso, LowPro, MET, MP3000, myCochlear, mySmartSound, NRT, Nucleus, Osia, Outcome Focused Fitting, Off-Stylet, Piezo Power, Profile, Slimline, SmartSound, Softip, SoundArc, True Wireless, the elliptical logo, Vistafix, Whisper, WindShield and Xidium are either trademarks or registered trademarks of the Cochlear group of companies. The names of actual companies and products mentioned herein may be the trademarks of their respective owners.

 

This material is intended for health professionals. If you are a consumer, please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always read the instructions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.

 

Cochlear ProNews is monitored Monday through Friday, excluding some holidays. Questions and inquiries submitted over the weekends or holidays may see a delay in response. For immediate assistance please contact us directly. You are solely responsible for your interactions with other members of our Websites. Cochlear reserves the right, but has no obligation, to monitor disputes or communications between you and other members of our Websites. For a full list of Cochlear’s terms of use, click here.